Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA site release/version indicator on the page was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedFooter now displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check80 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; no impact on study content or history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page history now shows a new revision entry v3.4.1 and removal of v3.4.0, indicating a minor administrative update to the history record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.